Molecular hydrogen accelerates the reversal of acute obstructive cholangitis‑induced liver dysfunction by restoring gap and tight junctions.
Zhiyang Zhu, Jianhua Yu, Weiguo Lin, Haijun Tang, Weiguang Zhang, Baochun Lu · Molecular medicine reports · 2019
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In rats, the mechanism of this phenomenon suggests that H₂ may have effectively attenuated AOC‑induced inflammatory and oxidative damage, and decreased matrix metalloproteinase activity. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in rats. The mechanism of this phenomenon suggests that H₂ may have effectively attenuated AOC‑induced inflammatory and oxidative damage, and decreased matrix metalloproteinase activity.
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
The present results confirmed that both inflammatory and oxidative damage induced aberrant TJ and GJ protein expression in hepatocytes in vitro. it also provided a possible mechanism underlying the H₂-mediated rescue of GJ and TJ protein expression, due to its reported anti‑oxidant and anti‑inflammatory properties. The mechanism of this phenomenon suggests that H₂ may have effectively attenuated AOC‑induced inflammatory and oxidative damage, and decreased matrix metalloproteinase activity. Molecular hydrogen (H₂) is regarded as an important physiological regulatory factor with antioxidant effects, which protect cells and organs from injury caused by reactive oxygen species (ROS) and oxidative stress (6-8). Molecular hydrogen attenuates AOC‑induced inflamma ‑ tory and oxidative damage.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The study used a preclinical animal experiment.
Limitations and Safety
Reported limitations: However, the chemical instability of H₂ is still the main limitation of its clinical application (6).
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base. The original scholarly source is available at https://www.spandidos-publications.com/10.3892/mmr.2019.10179/download.